Sigma NU Frat

Baylon Capital Management is a private investment partnership based in Boston, MA, that focuses on delivering long-term and tax-efficient capital appreciation through proactive risk management and moderate volatility. They primarily invest in liquid securities of listed companies that they believe are undervalued. The company is led by Scott A. Schoen, the Chief Executive Officer, who has extensive experience in the investment industry and has served on numerous corporate boards. Charles A. Mangum, the Chief Investment Officer, brings his expertise in healthcare and finance to the team. Together, they aim to generate substantial returns by identifying opportunities in the market.Generated from the website

The James M. & Cathleen D. Stone Foundation, operating in Boston, MA, focuses on fostering equity and addressing systemic disparities within the community. Through various funds and initiatives, the Foundation supports civic leadership, economic opportunity, and promotes social well-being to strengthen the surrounding neighborhoods. Dedicated to dismantling structural inequities, the Foundation collaborates with diverse partners, donors, and community leaders to implement impactful policies and practices. By investing strategically in local organizations and resources, the Foundation aims to build a more just and equitable Boston. Generated from the website

Aastrom Biosciences develops products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell adult stem cell technology. Aastrom's TRC products contain large numbers of stromal, stem and progenitor cells that are produced from a small amount of bone marrow cells originating from patients. Its patented AastromReplicell system, an industry-unique automated cell product manufacturing platform, was developed for the production of standardized, patient-specific TRC products. TRC products have been used safely in humans as a substitute for bone marrow stem cells and are currently in clinical trials for bone grafting and blood vessel regeneration applications. Aastrom Biosciences is located in Ann Arbor, Mich., and trades on the NASDAQ under the symbol ASTM.